Trial intelligence / Profile preview

Aspirin-Free Strategy After 3-6 Month DAPT in ACS Patients

NCT07736196Phase 4Not yet recruiting

Sponsor
Assiut University
Start
Jul 2026
Primary completion
Jul 2029
Countries
1
01

Overview

A Phase 4 trial of clopidogrel, ticagrelor in acute coronary syndrome (ACS), sponsored by Assiut University. Planned start Jul 2026; status: not yet recruiting.

02

Drugs

clopidogrelticagrelor
03

Conditions

acute coronary syndrome (ACS)

Beyond the preview

Go deeper on NCT07736196.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07736196.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call